Song M, Qiang Y, Zhao X, Song F
Mol Neurobiol. 2024; 61(10):7287-7302.
PMID: 38378992
DOI: 10.1007/s12035-024-04047-1.
Guo B, Zheng C, Cao J, Luo F, Li H, Hu S
J Adv Res. 2023; 64:195-211.
PMID: 37989471
PMC: 11464467.
DOI: 10.1016/j.jare.2023.11.021.
Miller N, Xu Z, Quinlan K, Ji A, McGivern J, Feng Z
Proc Natl Acad Sci U S A. 2023; 120(47):e2300308120.
PMID: 37976261
PMC: 10666147.
DOI: 10.1073/pnas.2300308120.
Xia L, Nie T, Lu F, Huang L, Shi X, Ren D
Autophagy. 2023; 20(3):505-524.
PMID: 37772772
PMC: 10936626.
DOI: 10.1080/15548627.2023.2259735.
Pluta A, Studniarek C, Murphy S, Norbury C
Wiley Interdiscip Rev RNA. 2023; :e1816.
PMID: 37718413
PMC: 10909489.
DOI: 10.1002/wrna.1816.
A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes.
Pao P, Seo J, Lee A, Kritskiy O, Patnaik D, Penney J
Proc Natl Acad Sci U S A. 2023; 120(16):e2217864120.
PMID: 37043533
PMC: 10120002.
DOI: 10.1073/pnas.2217864120.
The Role of MEF2 Transcription Factor Family in Neuronal Survival and Degeneration.
Lisek M, Przybyszewski O, Zylinska L, Guo F, Boczek T
Int J Mol Sci. 2023; 24(4).
PMID: 36834528
PMC: 9963821.
DOI: 10.3390/ijms24043120.
Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders.
Tian Z, Feng B, Wang X, Tian J
Front Mol Neurosci. 2022; 15:1030639.
PMID: 36438186
PMC: 9687395.
DOI: 10.3389/fnmol.2022.1030639.
A focus on natural products for preventing and cure of mitochondrial dysfunction in Parkinson's disease.
Mohammadipour A
Metab Brain Dis. 2022; 37(4):889-900.
PMID: 35156154
DOI: 10.1007/s11011-022-00931-8.
Involvement of myocyte enhancer factor 2c in the pathogenesis of autism spectrum disorder.
Chaudhary R, Agarwal V, Kaushik A, Rehman M
Heliyon. 2021; 7(4):e06854.
PMID: 33981903
PMC: 8082549.
DOI: 10.1016/j.heliyon.2021.e06854.
The Role of CDK5 in Tumours and Tumour Microenvironments.
Do P, Lee C
Cancers (Basel). 2021; 13(1).
PMID: 33396266
PMC: 7795262.
DOI: 10.3390/cancers13010101.
MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.
Xia X, Yu C, Bian M, Sun C, Tanasa B, Chang K
PLoS One. 2020; 15(12):e0242884.
PMID: 33315889
PMC: 7735573.
DOI: 10.1371/journal.pone.0242884.
Correlation between histone H3K4 trimethylation and DNA methylation and evaluation of the metabolomic features in acute rejection after kidney transplantation.
Zhang A, Xu Y, Sui X, Zhang Y, Gu F, Chen J
Am J Transl Res. 2020; 12(11):7565-7580.
PMID: 33312389
PMC: 7724326.
Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson's disease models through activating the MEF2-PGC1α and BDNF/CREB pathways.
Chen H, Cao J, Zha L, Wang P, Liu Z, Guo B
Aging (Albany NY). 2020; 12(14):14897-14917.
PMID: 32710729
PMC: 7425444.
DOI: 10.18632/aging.103551.
Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed.
Ayalew Mekonnen Y, Gultas M, Effa K, Hanotte O, Schmitt A
Front Genet. 2019; 10:1095.
PMID: 31803229
PMC: 6872528.
DOI: 10.3389/fgene.2019.01095.
Down-regulation of cyclin-dependent kinase 5 attenuates p53-dependent apoptosis of hippocampal CA1 pyramidal neurons following transient cerebral ischemia.
Shin B, Kim D, Kim I, Park J, Ahn J, Kang I
Sci Rep. 2019; 9(1):13032.
PMID: 31506563
PMC: 6737192.
DOI: 10.1038/s41598-019-49623-x.
Neuronal Myocyte-Specific Enhancer Factor 2D (MEF2D) Is Required for Normal Circadian and Sleep Behavior in Mice.
Mohawk J, Cox K, Sato M, Yoo S, Yanagisawa M, Olson E
J Neurosci. 2019; 39(40):7958-7967.
PMID: 31420455
PMC: 6774416.
DOI: 10.1523/JNEUROSCI.0411-19.2019.
Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases.
Zhu L, Wang D, Cui K, Liu D, Zhu L
Curr Neuropharmacol. 2019; 17(12):1146-1157.
PMID: 31362659
PMC: 7057204.
DOI: 10.2174/1570159X17666190726115623.
Emerging roles for MEF2 in brain development and mental disorders.
Assali A, Harrington A, Cowan C
Curr Opin Neurobiol. 2019; 59:49-58.
PMID: 31129473
PMC: 6874740.
DOI: 10.1016/j.conb.2019.04.008.
Salvianolic Acid B Inhibits Activation of Human Primary Hepatic Stellate Cells Through Downregulation of the Myocyte Enhancer Factor 2 Signaling Pathway.
Zhang W, Ping J, Zhou Y, Chen G, Xu L
Front Pharmacol. 2019; 10:322.
PMID: 31031620
PMC: 6470251.
DOI: 10.3389/fphar.2019.00322.